Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 19,300 shares at $126.41 ($2.4M) on 2021-07-19, disclosed to the SEC on 2021-07-21.
Open-market sale of $2.4M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.67 | 3,504 | $440K | 18.1% |
| 2 | $125.67 | 3,504 | $440K | 18.1% |
| 3 | $126.41 | 4,472 | $565K | 23.2% |
| 4 | $126.41 | 4,472 | $565K | 23.2% |
| 5 | $127.36 | 1,324 | $169K | 6.9% |
| 6 | $127.36 | 1,324 |
| $169K |
| 6.9% |
| 7 | $128.71 | 700 | $90K | 3.7% |
| Total | $126.36 avg | 19,300 | $2.4M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |
| CRSP | SELL | 2021-03-24 | $8.0M | — | Filing → |